124 related articles for article (PubMed ID: 38079329)
21. Synthesis and Biological Evaluation of Substituted Pyrazole-Fused Oleanolic Acid Derivatives as Novel Selective α-Glucosidase Inhibitors.
Gao M; Ma H; Liu X; Zhang Y; Tang L; Zheng Z; Zhang X; Jiang C; Lin L; Sun H
Chem Biodivers; 2023 Feb; 20(2):e202201178. PubMed ID: 36573561
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, α-amylase and α-glucosidase inhibition and molecular docking studies of indazole derivatives.
Nawaz M; Taha M; Qureshi F; Ullah N; Selvaraj M; Shahzad S; Chigurupati S; Abubshait SA; Ahmad T; Chinnam S; Hisaindee S
J Biomol Struct Dyn; 2022; 40(21):10730-10740. PubMed ID: 34463216
[TBL] [Abstract][Full Text] [Related]
23. Study on the Interaction of 1,5-diaryl Pyrrole Derivatives with α- glucosidase; Synthesis, Molecular Docking, and Kinetic Study.
Tafesse TB; Moghadam ES; Bule MH; Faramarzi MA; Abdollahi M; Amini M
Med Chem; 2021; 17(5):545-553. PubMed ID: 31808390
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, in vitro, and in silico enzymatic evaluations of thieno[2,3-b]quinoline-hydrazones as novel inhibitors for α-glucosidase.
Noori M; Rastak M; Halimi M; Ghomi MK; Mollazadeh M; Mohammadi-Khanaposhtani M; Sayahi MH; Rezaei Z; Mojtabavi S; Ali Faramarzi M; Larijani B; Biglar M; Amanlou M; Mahdavi M
Bioorg Chem; 2022 Oct; 127():105996. PubMed ID: 35878449
[TBL] [Abstract][Full Text] [Related]
25. Novel Bis-Schiff's base derivatives of 4-nitroacetophenone as potent α-glucosidase agents: Design, synthesis and in silico approach.
Alam A; Ali M; Latif A; Rehman NU; Saher S; Zainab ; Faryal ; Khan A; Ullah S; Ullah O; Halim SA; Sani F; Al-Harrasi A; Ahmad M
Bioorg Chem; 2022 Nov; 128():106058. PubMed ID: 35917750
[TBL] [Abstract][Full Text] [Related]
26. Indane-1,3-diones: As Potential and Selective α-glucosidase Inhibitors, their Synthesis, in vitro and in silico Studies.
Mukhtar A; Shah S; Kanwal ; Hameed S; Khan KM; Khan SU; Zaib S; Iqbal J; Perveen S
Med Chem; 2021; 17(8):887-902. PubMed ID: 32851965
[TBL] [Abstract][Full Text] [Related]
27. Novel oxadiazole derivatives as potent inhibitors of α-amylase and α-glucosidase enzymes: Synthesis,
Bukhari A; Nadeem H; Imran M; Muhammad SA
Iran J Basic Med Sci; 2021 Dec; 24(12):1632-1642. PubMed ID: 35432813
[TBL] [Abstract][Full Text] [Related]
28. Bioactivity-Guided Synthesis: In Silico and In Vitro Studies of
Khushal A; Farooq U; Khan S; Rasul A; Wani TA; Zargar S; Shahzad SA; Bukhari SM; Khan NA
Molecules; 2023 Sep; 28(18):. PubMed ID: 37764324
[TBL] [Abstract][Full Text] [Related]
29.
Awan ZA; Khan HA; Jamal A; Shams S; Zheng G; Wadood A; Shahab M; Khan MI; Kalantan AA
J Biomol Struct Dyn; 2024 Jan; ():1-11. PubMed ID: 38294714
[TBL] [Abstract][Full Text] [Related]
30. Isolated compounds from Dracaena angustifolia Roxb and acarbose synergistically/additively inhibit α-glucosidase and α-amylase: an in vitro study.
Yi J; Zhao T; Zhang Y; Tan Y; Han X; Tang Y; Chen G
BMC Complement Med Ther; 2022 Jul; 22(1):177. PubMed ID: 35780093
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, in vitro and in silico screening of 2-amino-4-aryl-6-(phenylthio) pyridine-3,5-dicarbonitriles as novel α-glucosidase inhibitors.
Ali M; Khan KM; Mahdavi M; Jabbar A; Shamim S; Salar U; Taha M; Perveen S; Larijani B; Faramarzi MA
Bioorg Chem; 2020 Jul; 100():103879. PubMed ID: 32413625
[TBL] [Abstract][Full Text] [Related]
32. Novel enantiopure isoxazolidine and C-alkyl imine oxide derivatives as potential hypoglycemic agents: Design, synthesis, dual inhibitors of α-amylase and α-glucosidase, ADMET and molecular docking study.
Ghannay S; Snoussi M; Messaoudi S; Kadri A; Aouadi K
Bioorg Chem; 2020 Nov; 104():104270. PubMed ID: 32947132
[TBL] [Abstract][Full Text] [Related]
33. Novel inhibitors with sulfamethazine backbone: synthesis and biological study of multi-target cholinesterases and α-glucosidase inhibitors.
Türkeş C; Akocak S; Işık M; Lolak N; Taslimi P; Durgun M; Gülçin İ; Budak Y; Beydemir Ş
J Biomol Struct Dyn; 2022; 40(19):8752-8764. PubMed ID: 33950796
[TBL] [Abstract][Full Text] [Related]
34. New cycloalkyl[b]thiophenylnicotinamide-based α-glucosidase inhibitors as promising anti-diabetic agents: Synthesis, in silico study, in vitro and in vivo evaluations.
Wang KM; Ge YX; Zhang J; Chen YT; Zhang NY; Gu JS; Fang L; Zhang XL; Zhang J; Jiang CS
Bioorg Med Chem Lett; 2023 Jan; 79():129069. PubMed ID: 36395995
[TBL] [Abstract][Full Text] [Related]
35. Biochemical and computational inhibition of α-glucosidase by novel metronidazole-linked 1
Ullah S; Halim SA; Waqas M; Mansoor F; Avula SK; Khan FA; Perviaz M; Ogaly HA; Khan A; Al-Harrasi A
J Biomol Struct Dyn; 2024 Mar; ():1-21. PubMed ID: 38433423
[TBL] [Abstract][Full Text] [Related]
36. Design and synthesis of novel pyrazole-phenyl semicarbazone derivatives as potential α-glucosidase inhibitor: Kinetics and molecular dynamics simulation study.
Azimi F; Ghasemi JB; Azizian H; Najafi M; Faramarzi MA; Saghaei L; Sadeghi-Aliabadi H; Larijani B; Hassanzadeh F; Mahdavi M
Int J Biol Macromol; 2021 Jan; 166():1082-1095. PubMed ID: 33157144
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of the chromone-thiosemicarbazone scaffold as promising α-glucosidase inhibitors: An in vitro and in silico approach toward antidiabetic drug design.
Alharthy RD; Khalid S; Fatima S; Ullah S; Khan A; Mali SN; Jawarkar RD; Dhabarde SS; Kashtoh H; Taslimi P; Al-Harrasi A; Shafiq Z; Boshta NM
Arch Pharm (Weinheim); 2024 Apr; ():e2400140. PubMed ID: 38687119
[TBL] [Abstract][Full Text] [Related]
38. Quinazolinone-dihydropyrano[3,2-b]pyran hybrids as new α-glucosidase inhibitors: Design, synthesis, enzymatic inhibition, docking study and prediction of pharmacokinetic.
Sherafati M; Mirzazadeh R; Barzegari E; Mohammadi-Khanaposhtani M; Azizian H; Sadegh Asgari M; Hosseini S; Zabihi E; Mojtabavi S; Ali Faramarzi M; Mahdavi M; Larijani B; Rastegar H; Hamedifar H; Hamed Hajimiri M
Bioorg Chem; 2021 Apr; 109():104703. PubMed ID: 33609917
[TBL] [Abstract][Full Text] [Related]
39. Benzimidazole Bearing Thiosemicarbazone Derivatives Act as Potent α-Amylase and α-Glucosidase Inhibitors; Synthesis, Bioactivity Screening and Molecular Docking Study.
Ullah H; Khan S; Rahim F; Taha M; Iqbal R; Sarfraz M; Shah SAA; Sajid M; Awad MF; Omran A; Albalawi MA; Abdelaziz MA; Al Areefy A; Jafri I
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296520
[TBL] [Abstract][Full Text] [Related]
40. Discovery of Amide-Functionalized Benzimidazolium Salts as Potent α-Glucosidase Inhibitors.
Khan IA; Ahmad M; Ashfaq UA; Sultan S; Zaki MEA
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
